× Medicines Discovery Catapult

Our leadership team brings decades of broad management and technical expertise from across our industrial sectors and disciplines. Our team specialises in areas of science, technology, collaboration and understand the needs of SMEs, pharma companies, service providers, charities and investors. The team is determined to make a real difference to how high value products are discovered and proven, and to support the future of UK discovery.

Chris Molloy

Chief Executive Officer

Chris has over 25 years of international Executive and Board experience across multiple areas of medicines discovery. He began his career in discovery biology at GSK and has delivered [...]

Read more

Professor John Overington

Chief Informatics Officer

John joined the Medicines Discovery Catapult as Chief Informatics Officer in April 2017 from technology company BenevolentAI, where he was involved in the development of novel data extraction and [...]

Read more

Dr Marcus Harrison

Chief Operating Officer

Marcus joined the Medicines Discovery Catapult as Chief Operating Officer in April 2017 and assumes overall responsibility for the operational functions, including Finance, HR, Facilities, Procurement, IT and Legal [...]

Read more

Dr Peter Simpson

Chief Scientific Officer

Peter has most recently been the Director of N8 Research Partnership, the not-for-profit body that establishes multi-university research collaborations across the North of England. Peter led strategic engagement on [...]

Read more

Mark Samuels

Chief Business & Strategy Officer

Mark was previously the founding MD of the National Institute for Health Research Office for Clinical Research Infrastructure (NOCRI) and a founder member of the NIHR Strategy Board. The [...]

Read more

Science & Technology

Informatics

Virtual R&D

Discovery Syndicates

Samples and Data